IPO

Prevest Denpro Limited IPO

BSE SME

Listed On: Sep 27, 2021 at ₹ 180.55

₹ 268800 /3200 Shares
*Min Investment

Check Allotment

15 Sep, 2021

Open Date

17 Sep, 2021

Close Date

22 Sep, 2021

Allotment Date

27 Sep, 2021

Listing Date
IPO Issue Details
  • Issue Price ₹82 to ₹84 per equity share
  • Face Value ₹10 Per Equity Share 
  • Issue Price Fresh Issue of 3,168,000 Eq Shares of ₹10 (aggregating up to ₹26.61 Cr)
  • Listing at BSE SME
  • List Price 180.55
  • Listing Date 2021-09-27
  • Lead Manager Hem Securities Limited
  • Registrar Bigshare Services Pvt Ltd
IPO Details
  • Retail Portion N/A
IPO Documents
IPO Details


Prevest Denpro Limited IPO is an SME IPO, priced at ₹82 to ₹84 per equity share. The equity shares have a face value of ₹10 Per Equity Share  each and will be listed on the BSE SME platform.

The IPO bidding window is open from Sep 15, 2021 to Sep 17, 2021. The allotment is expected to be finalized on Sep 22, 2021, and the tentative listing date is Sep 27, 2021.


The registrar of the IPO is Bigshare Services Pvt Ltd, and

Read More
IPO Subscription Analysis And Details
Retail
32.87x
Total
38.12x
As on QIB / NII Retail Total
Shares Offered / Reserved 601,600/611,200 1,052,800 2,265,600
Day 1 15-09-21 05:00 PM
0.50/0.63 x 1.33 x 0.92 x
Day 2 16-09-21 05:00 PM
1.96/3.58 x 7.93 x 5.17 x
Day 3 17-09-21 05:00 PM
5.78/79.98 x 32.87 x 38.12 x
Valuations
Earnings Per Share (EPS) ₹6.2/-
P/E Ratio 13.55
RoNW 32.71
Net Asset Value (NAV) - Post Issue ₹25.74/-
Company Financials
In Crs.
In Cr.
31-Mar-21 31-Mar-20 31-Mar-19
Assets 30.69 21.07 15.34
Revenue 29.51 24.55 19.77
Profit After Tax 7.43 5.00 2.99
About Company

Prevest Denpro manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile. The company’s product portfolio includes materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry, and laboratory consumables.

The company's products are sold in around 75 countries and in F.Y. 2020-21, 60.24% of the company’s sales were from markets outside India. The company’s manufacturing facility is located at Kartholi, Samba (Jammu & Kashmir), comprising of over 27,000 sq. ft. area and an installed capacity of 200 MT p.a. for manufacturing of dental materials. The company is also adding another manufacturing facility adjacent to their current manufacturing plant in over 16,000 sq. ft. mainly for producing hygiene, oral care, and bio-materials products.

Read More
- Promoter(s)

Pre Issue Share Holding : 100%

Post Issue Share Holding : 73.60%

IPO - Issue Objectives
1

Purchase of machineries, equipment’s, and utilities for manufacturing of proposed additional line of products, R&D unit, and existing manufacturing operations.

2

General Corporate Purpose.

3

To meet issue expenses.